Literature DB >> 35518812

Ten-year trends in adrenal insufficiency admissions.

Hafeez Shaka1, Shannon Manz2, Zain El-Amir2, Farah Wani2, Michael Salim3, Asim Kichloo2,4.   

Abstract

Adrenal insufficiency (AI) is a severe disease that is difficult to manage in both inpatient and outpatient settings. This study describes trends, inpatient outcomes, and the disease burden of hospitalizations for patients with AI. Data are included on hospitalizations with a principal discharge diagnosis of AI using ICD codes from the National Inpatient Sample for the years 2008, 2010, 2012, 2014, 2016, and 2018. Patients <18 years and those with elective hospitalizations were excluded. From 2008 to 2018, the number of AI hospitalizations increased significantly (P-trend < 0.001), with a rising trend in the proportion of patients with Charlson Comorbidity Index scores >3. There was a significant downward trend in the length of stay from 2008 to 2018 (P-trend = 0.005). However, there was no statistically significant trend for mortality or mean total hospital charges during hospitalizations (P-trend = 0.050 and 0.076, respectively). In conclusion, AI hospitalizations significantly increased over the 10 years with an overall decrease in length of stay.
Copyright © 2022 Baylor University Medical Center.

Entities:  

Keywords:  Adrenal insufficiency; hospitalizations; outcomes; trends

Year:  2022        PMID: 35518812      PMCID: PMC9037407          DOI: 10.1080/08998280.2022.2039503

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  18 in total

Review 1.  Adjusting Health Expenditures for Inflation: A Review of Measures for Health Services Research in the United States.

Authors:  Abe Dunn; Scott D Grosse; Samuel H Zuvekas
Journal:  Health Serv Res       Date:  2016-11-21       Impact factor: 3.402

Review 2.  Immune-related adverse events of checkpoint inhibitors.

Authors:  Manuel Ramos-Casals; Julie R Brahmer; Margaret K Callahan; Alejandra Flores-Chávez; Niamh Keegan; Munther A Khamashta; Olivier Lambotte; Xavier Mariette; Aleix Prat; Maria E Suárez-Almazor
Journal:  Nat Rev Dis Primers       Date:  2020-05-07       Impact factor: 52.329

3.  Increased Mortality Risk in Patients With Primary and Secondary Adrenal Insufficiency.

Authors:  Kanchana Ngaosuwan; Desmond G Johnston; Ian F Godsland; Jeremy Cox; Azeem Majeed; Jennifer K Quint; Nick Oliver; Stephen Robinson
Journal:  J Clin Endocrinol Metab       Date:  2021-06-16       Impact factor: 5.958

4.  Exploring Inpatient Hospitalizations and Morbidity in Patients With Adrenal Insufficiency.

Authors:  Paul M Stewart; Beverly M K Biller; Claudio Marelli; Candace Gunnarsson; Michael P Ryan; Gudmundur Johannsson
Journal:  J Clin Endocrinol Metab       Date:  2016-09-13       Impact factor: 5.958

5.  Gender, race and socioeconomic influence on diagnosis and treatment of thyroid disorders in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).

Authors:  R D Olmos; R C de Figueiredo; E M Aquino; P A Lotufo; I M Bensenor
Journal:  Braz J Med Biol Res       Date:  2015-06-23       Impact factor: 2.590

Review 6.  Endocrine manifestations in celiac disease.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2016-10-14       Impact factor: 5.742

7.  Health Care Burden in Patients With Adrenal Insufficiency.

Authors:  Candace Gunnarsson; Michael P Ryan; Claudio Marelli; Erin R Baker; Paul M Stewart; Gudmundur Johannsson; Beverly M K Biller
Journal:  J Endocr Soc       Date:  2017-04-12

Review 8.  Adrenal crisis: prevention and management in adult patients.

Authors:  Rosemary Dineen; Christopher J Thompson; Mark Sherlock
Journal:  Ther Adv Endocrinol Metab       Date:  2019-06-13       Impact factor: 3.565

9.  Why women have more autoimmune diseases than men: An evolutionary perspective.

Authors:  Vanessa L Kronzer; Stanley Louis Bridges; John M Davis
Journal:  Evol Appl       Date:  2020-12-01       Impact factor: 5.183

Review 10.  Adrenal insufficiency - recognition and management.

Authors:  Agnieszka Pazderska; Simon Hs Pearce
Journal:  Clin Med (Lond)       Date:  2017-06       Impact factor: 2.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.